Skip to content
DrBrainRXDrBrainRX
0
Personalized care from experts
Personalized care from experts
Fast & discreet shipping
Fast & discreet shipping
100% online visits
100% online visits
Personalized care from experts
Personalized care from experts
Fast & discreet shipping
Fast & discreet shipping
100% online visits
100% online visits

Reinvent your‎ ‎ Brain Body Passion Beauty

Personalized care from experts

Personalized care from experts

Fast & discreet shipping

Fast & discreet shipping

100% online visits

100% online visits

The Science of CJC + Ipamorelin for Growth and Recovery

The Science of CJC + Ipamorelin for Growth and Recovery

How They Work

CJC-1295 (a GHRH analog) and Ipamorelin (a GHRP) signal your pituitary to release your own growth hormone pulses. CJC extends the pulse window; Ipamorelin amplifies it without raising cortisol or prolactin.

Together, they enhance natural GH rhythm, maintaining healthy IGF-1 levels—crucial for cellular repair, bone density, and fat metabolism.

 


 

Clinical Benefits

  • Faster recovery after exercise or injury

  • Increased lean mass and improved body composition

  • Deeper sleep and vivid dreaming from normalized GH-melatonin rhythm

  • Sharper focus and higher morning energy

  • Better skin tone through collagen synthesis

Studies show consistent nightly dosing can raise IGF-1 20–50 percent above baseline within three months.

 


 

Protocol and Expectations

Typical dosing: 300 mcg CJC + 300 mcg Ipamorelin nightly, injected subcutaneously 30 minutes before bed on an empty stomach.
Results evolve gradually—most patients notice better sleep and recovery by week 3, visible body-composition changes by week 8–12.

 


 

Why It’s Different from GH Injections

Unlike synthetic growth hormone, this approach preserves pituitary sensitivity and negative feedback, reducing the risk of water retention or insulin resistance.

 


 

Optimize Your Recovery

Rebuild stronger with evidence-based peptide protocols at drbrainrx.com.

References: Rahim A et al., J Clin Endocrinol Metab. 2022 | Koniver C et al., Front Aging Sci. 2024

Cart 0

Your cart is currently empty.

Start Shopping